Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Nosbaum

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Dermatology : EJD|April 7, 2018
Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitisBenjamine Delcasso, Catherine Goujon, Florence Hacard, et al.
Journal of Dermatological Science|September 6, 2015
Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibioticsBenoit Ben-Said, Ségolène Arnaud-Butel, Aurore Rozières, et al.
European Journal of Dermatology : EJD|February 13, 2015
Residents' corner December 2014. Residents' editorial choice: what's new this month?Rubeta N H Matin, Alejandro Martin-Gorgojo, Ana Rita Travassos, et al.
Frontiers in Allergy|March 26, 2024
Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxisLoris Guyénard, Marie Tauber, Sophie Debord-Peguet, et al.
The Journal of Dermatological Treatment|June 22, 2023
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitisJacob P Thyssen, Thomas Bieber, C Elise Kleyn, et al.
The Journal of Dermatological Treatment|November 15, 2023
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient surveyMatthias Augustin, Audrey Nosbaum, Thomas Werfel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Immediate allergic hypersensitivity to quinolones associates with neuromuscular blocking agent sensitizationPaul Rouzaire, Audrey Nosbaum, Christine Mullet, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 18, 2015
Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitisAngèle Cortial, Audrey Nosbaum, Aurore Rozières, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Reply: To PMID 24565485Paul Rouzaire, Audrey Nosbaum, Christine Mullet, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
Comprehensive Ophthalmological Evaluation in Atopic DermatitisAnaïs Valeille, Coralie Ouilhon, Fabien Subtil, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Dermatology : EJD|April 7, 2018
Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitisBenjamine Delcasso, Catherine Goujon, Florence Hacard, et al.
Journal of Dermatological Science|September 6, 2015
Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibioticsBenoit Ben-Said, Ségolène Arnaud-Butel, Aurore Rozières, et al.
European Journal of Dermatology : EJD|February 13, 2015
Residents' corner December 2014. Residents' editorial choice: what's new this month?Rubeta N H Matin, Alejandro Martin-Gorgojo, Ana Rita Travassos, et al.
Frontiers in Allergy|March 26, 2024
Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxisLoris Guyénard, Marie Tauber, Sophie Debord-Peguet, et al.
The Journal of Dermatological Treatment|June 22, 2023
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitisJacob P Thyssen, Thomas Bieber, C Elise Kleyn, et al.
The Journal of Dermatological Treatment|November 15, 2023
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient surveyMatthias Augustin, Audrey Nosbaum, Thomas Werfel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Immediate allergic hypersensitivity to quinolones associates with neuromuscular blocking agent sensitizationPaul Rouzaire, Audrey Nosbaum, Christine Mullet, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 18, 2015
Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitisAngèle Cortial, Audrey Nosbaum, Aurore Rozières, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Reply: To PMID 24565485Paul Rouzaire, Audrey Nosbaum, Christine Mullet, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
Comprehensive Ophthalmological Evaluation in Atopic DermatitisAnaïs Valeille, Coralie Ouilhon, Fabien Subtil, et al.
Pageof 12